W
WllyBIO
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X | 1 | 3.6 | 3.6 | 3.6 | 3 Jul 2025 |
| 5-amino-1MQ | X | 1 | 4.0 | 3.6 | 3.6 | 25 Apr 2025 |
| ACE-031 | X | 1 | 4.0 | 2.0 | 2.0 | 24 Apr 2025 |
| AICAR | X | 1 | 4.0 | 0.9 | 0.9 | 24 Apr 2025 |
| Anastrozole (Arimidex) Raw | X | 1 | 4.0 | 2.2 | 2.2 | 16 Mar 2025 |
| Andarine S4 | X | 1 | 5.3 | 5.3 | 5.3 | 9 Jun 2025 |
| ARA-290 | X | 1 | 5.4 | 5.4 | 5.4 | 3 Jun 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X | 1 | 5.3 | 5.3 | 5.3 | 16 Mar 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X | 1 | 4.6 | 4.6 | 4.6 | 20 Jun 2025 |
| Cerebrolysin | X | 1 | 4.9 | 4.9 | 4.9 | 3 Jul 2025 |
| Chonluten | X | 1 | 4.0 | 3.6 | 3.6 | 21 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X | 1 | 4.0 | 4.0 | 4.0 | 7 May 2025 |
| EPO | X | 1 | 4.0 | 3.7 | 3.7 | 7 May 2025 |
| Equipoise (Boldenone Undecylenate) | X | 1 | 4.0 | 3.7 | 3.7 | 14 Jan 2025 |
| GHRP-2 Acetate | X | 1 | 4.0 | 2.3 | 2.3 | 3 Jun 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X | 1 | 4.0 | 3.5 | 3.5 | 2 Jul 2025 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X | 1 | 4.0 | 2.3 | 2.3 | 9 Jun 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 4.0 | 2.8 | 2.8 | 16 Mar 2025 |
| KPV Oral | X | 1 | 4.0 | 4.0 | 4.0 | 8 Jul 2025 |
| MENT (Trestolone Acetate) | X | 1 | 4.0 | 3.7 | 3.7 | 2 Jul 2025 |
| Methylstenbolone | X | 1 | 5.2 | 5.2 | 5.2 | 28 Mar 2025 |
| MOTS-C | X | 1 | 4.0 | 3.0 | 3.0 | 21 May 2025 |
| NA Semax Amidate | X | 1 | 6.2 | 6.2 | 6.2 | 3 Jul 2025 |
| Orforglipron | X | 1 | 4.0 | 2.1 | 2.1 | 6 May 2025 |
| Pancragen | X | 1 | 4.0 | 3.3 | 3.3 | 17 Dec 2024 |
| PE 22-28 | X | 1 | 4.0 | 3.8 | 3.8 | 8 Jul 2025 |
| Pinealon | X | 1 | 4.0 | 1.8 | 1.8 | 8 Jul 2025 |
| PMK methyl glycidate CAS 1369021-80-6 | X | 1 | 4.0 | 2.5 | 2.5 | 24 Apr 2025 |
| Prednisone | X | 1 | 4.2 | 4.2 | 4.2 | 16 Mar 2025 |
| PTD-DBM | X | 1 | 4.0 | 1.9 | 1.9 | 27 Feb 2025 |
| Selank | X | 1 | 4.0 | 2.3 | 2.3 | 14 Jan 2025 |
| Semax | X | 1 | 4.0 | 3.3 | 3.3 | 25 Apr 2025 |
| SNAP-8 | X | 1 | 4.0 | 2.8 | 2.8 | 6 May 2025 |
| SR9009 | X | 1 | 4.0 | 3.7 | 3.7 | 24 Apr 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X | 1 | 6.8 | 6.8 | 6.8 | 7 May 2025 |
| Test Enanthate | X | 1 | 4.3 | 4.3 | 4.3 | 2 Apr 2025 |
| Thymosin Alpha-1 | X | 1 | 4.0 | 1.7 | 1.7 | 20 Jun 2025 |
| Trestolone Enanthate Raw | X | 1 | 5.4 | 5.4 | 5.4 | 28 Mar 2025 |
| Vilon | X | 1 | 4.2 | 4.2 | 4.2 | 2 Apr 2025 |
| Winstrol Oil | X | 1 | 4.6 | 4.6 | 4.6 | 28 Mar 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Methylstenbolone | 7.7 | 10mg | 11.6mg | +15.6% | 95.58% | Lab F |
| 25 May 2026 | SR9009 | 5.3 | 25mg | 31.2mg | +24.7% | 97.76% | Lab G |
| 24 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 4.0 | 500g | 496.6g | -0.7% | 98.31% | Lab F |
| 24 May 2026 | EPO | 4.0 | 30mg | 25.8mg | -14.0% | 99.20% | Lab F |
| 24 May 2026 | GHRP-2 Acetate | 4.0 | 15mg | 14.1mg | -6.0% | 95.34% | Lab F |
| 24 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.5 | 30mg | 32.2mg | +7.2% | 97.74% | Lab G |
| 24 May 2026 | Equipoise (Boldenone Undecylenate) | 4.0 | 200mg/ml | 181.3mg/ml | -9.3% | 97.55% | Lab G |
| 23 May 2026 | MOTS-C | 4.7 | 10mg | 8.8mg | -11.6% | 96.50% | Lab G |
| 23 May 2026 | SNAP-8 | 5.5 | 20mg | 23.9mg | +19.5% | 96.40% | Lab C |
| 23 May 2026 | ACE-031 | 4.3 | 20mg | 17.5mg | -12.3% | 96.53% | Lab G |
| 23 May 2026 | Chonluten | 6.1 | 2mg | 1.8mg | -11.9% | 96.80% | Lab D |
| 21 May 2026 | ARA-290 | 8.2 | 15mg | 16.0mg | +6.3% | 97.20% | Lab G |
| 21 May 2026 | Cerebrolysin | 5.2 | 15mg | 18.3mg | +22.3% | 97.14% | Lab F |
| 21 May 2026 | NA Semax Amidate | 9.6 | 30mg | 27.3mg | -9.1% | 97.54% | Lab A |
| 21 May 2026 | PE 22-28 | 4.0 | 10mg | 9.2mg | -8.1% | 97.53% | Lab E |
| 20 May 2026 | PMK methyl glycidate CAS 1369021-80-6 | 5.5 | 5g | 6.2g | +23.5% | 95.49% | Lab F |
| 20 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 7.4 | 50mg | 58.7mg | +17.5% | 99.63% | Lab E |
| 17 May 2026 | 5-amino-1MQ | 4.0 | 15mg | 17.3mg | +15.6% | 99.51% | Lab F |
| 17 May 2026 | Anastrozole (Arimidex) Raw | 4.0 | 100g | 100.0g | +0.0% | 95.81% | Lab B |
| 17 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 4.0 | 300mg/ml | 311.3mg/ml | +3.8% | 98.97% | Lab E |
| 17 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.0 | 5mg | 6.2mg | +23.0% | 97.93% | Lab E |
| 17 May 2026 | Orforglipron | 5.4 | 100mg | 123.2mg | +23.2% | 96.61% | Lab G |
| 17 May 2026 | PTD-DBM | 4.0 | 15mg | 12.8mg | -14.3% | 95.93% | Lab B |
| 29 Jan 2026 | Semax | 5.0 | 50mg | 43.9mg | -12.2% | 96.49% | Lab F |
| 26 Jan 2026 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 5.1 | 250mg/ml | 224.2mg/ml | -10.3% | 99.05% | Lab E |
| 26 Jan 2026 | Thymosin Alpha-1 | 4.0 | 5mg | 4.4mg | -11.6% | 96.43% | Lab D |
| 19 Jan 2026 | MENT (Trestolone Acetate) | 4.2 | 200mg/ml | 197.5mg/ml | -1.3% | 95.80% | Lab B |
| 9 Jan 2026 | Prednisone | 4.2 | 100mg | 97.0mg | -3.0% | 98.09% | Lab F |
| 7 Jan 2026 | AICAR | 5.4 | 10mg | 9.4mg | -6.3% | 98.80% | Lab F |
| 7 Jan 2026 | Test Enanthate | 4.7 | 100mg/ml | 106.3mg/ml | +6.3% | 95.38% | Lab D |
| 6 Jan 2026 | Pinealon | 4.0 | 2mg | 2.0mg | -1.0% | 99.22% | Lab D |
| 5 Dec 2025 | Andarine S4 | 6.1 | 50mg | 48.1mg | -3.7% | 96.11% | Lab F |
| 5 Dec 2025 | KPV Oral | 4.0 | 25mg | 26.1mg | +4.3% | 97.50% | Lab B |
| 23 Nov 2025 | Winstrol Oil | 4.8 | 100mg/ml | 110.7mg/ml | +10.7% | 97.39% | Lab E |
| 17 Nov 2025 | Vilon | 4.0 | 30mg | 26.7mg | -11.0% | 99.01% | Lab B |
| 14 Nov 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.4 | 10mg | 10.4mg | +3.7% | 95.45% | Lab B |
| 14 Nov 2025 | Trestolone Enanthate Raw | 6.4 | 1g | 1.2g | +16.6% | 97.65% | Lab E |
| 5 Nov 2025 | Selank | 4.0 | 5mg | 5.7mg | +13.0% | 96.50% | Lab C |
| 3 Oct 2025 | Pancragen | 4.0 | 5mg | 4.8mg | -4.2% | 95.99% | Lab A |
| 3 Jul 2025 | Retatrutide | 3.6 | 5mg | 3.96mg | -20.8% | 99.31% | Lab E |